BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 16, 2009
View Archived Issues
FYX-051 shows potent serum uric acid-lowering activity in rats
Read More
AstraZeneca reports results from third quarter of 2009
Read More
Dainippon Sumimoto reports results from Q2 of the year ending March 31, 2010
Read More
Analyses of phase III data detail activity of fidaxomicin against C. difficile infection
Read More
AST-120 improves pruritus in patients with chronic liver disease
Read More
ITMN-191 monotherapy for HCV infection correlates with high barrier to viral escape
Read More
BMS-650032 shows potent anti-HCV activity in two phase II trials
Read More
Schering-Plough claims gamma-secretase modulators for AD therapy
Read More
arGentis to initiate first-in-human clinical trial of ARG-301 in rheumatoid arthritis
Read More
Adeona launches CopperProof Test for AD and cognitive impairment
Read More
PulmoBind has potential to diagnose conditions affecting pulmonary circulation
Read More
Pikamab to customize cancer antibody therapies with ADCC Therasight
Read More
Hybrigenics to meet with EMEA to discuss phase II trial of inecalcitol
Read More
Astex Therapeutics and GSK enter into strategic drug discovery alliance
Read More
Clinuvel to file MAA with EMEA for its photoprotective drug afamelanotide
Read More
Diamyd Medical completes enrollment in a phase III trial of Diamyd
Read More
First patient treated in phase IIb trial of 4SC-101 in rheumatoid arthritis
Read More
Bristol-Myers Squibb and Alder Biopharmaceuticals enter global RA biologic agreement
Read More
Avanir presents safety and efficacy data from STAR trial of Zenvia in PBA
Read More
Novel PI3K and mTOR inhibitors described by Wyeth as oncolytics
Read More
Novartis developing novel protease inhibitors for AD and other conditions
Read More
Merck KGaA reports dual-acting 5-HT reuptake inhibitors/5-HT1A receptor agonists
Read More
Phase I/II data show VIR-576 to be safe and effective in HIV
Read More
Promising preclinical and phase IIa data on S/GSK-1349572 disclosed
Read More
Bristol-Myers Squibb to split off its holdings in Mead Johnson
Read More
Merck & Co. completes enrollment in phase III clinical trial of SCH-530348
Read More